Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
VAMP5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LSM3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
RPL30 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLC28A1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HMGN2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CCT6B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PATJ - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LOC55338 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC101927137 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
APLP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LGI2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ADH5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FOLR2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DCXR - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ATRNL1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NMT2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PDC - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TCEB2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on